Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related TEVA
It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date
Vetr Issues Strong Buy As Teva Trends Down
The Vetr community has downgraded $TEVA to 3.5-Stars (Vetr)
Related QEP
Benzinga's Option Alert Recap From January 26
Watch These 8 Huge Put Purchases In Thursday Trade

Analysts at JP Morgan downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “overweight” to “neutral.” The target price for Teva has been lowered from $45 to $43. Teva's shares closed at $38.88 yesterday.

Deutsche Bank downgraded QEP Resources (NYSE: QEP) from “buy” to “hold.” The target price for QEP Resources has been lowered from $37 to $34. QEP Resources' shares closed at $28.78 yesterday.

Baird downgraded Brady (NYSE: BRC) from “outperform” to “neutral.” The target price for Brady has been lowered from $41 to $33. Brady's shares closed at $30.52 yesterday.

Analysts at DA Davidson downgraded Under Armour (NYSE: UA) from “buy” to “neutral.” Under Armour's shares closed at $80.59 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Feb 2017ArgusDowngradesHold
Feb 2017MizuhoDowngradesNeutralUnderperform
Jan 2017Bank of AmericaUpgradesNeutralBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BRC + QEP)

View Comments and Join the Discussion!